These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30158126)

  • 21. High-density lipoproteins suppress chemokines and chemokine receptors in vitro and in vivo.
    Bursill CA; Castro ML; Beattie DT; Nakhla S; van der Vorst E; Heather AK; Barter PJ; Rye KA
    Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1773-8. PubMed ID: 20702809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumors.
    Beavis PA; Divisekera U; Paget C; Chow MT; John LB; Devaud C; Dwyer K; Stagg J; Smyth MJ; Darcy PK
    Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14711-6. PubMed ID: 23964122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contribution of atypical chemokine receptor 2/ackr2 in bone remodeling.
    Lima ILA; Silva JMD; Rodrigues LFD; Madureira DF; Fonseca AC; Garlet GP; Teixeira MM; Russo RC; Fukada SY; Silva TAD
    Bone; 2017 Aug; 101():113-122. PubMed ID: 28476575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective role of the inflammatory CCR2/CCL2 chemokine pathway through recruitment of type 1 cytotoxic γδ T lymphocytes to tumor beds.
    Lança T; Costa MF; Gonçalves-Sousa N; Rei M; Grosso AR; Penido C; Silva-Santos B
    J Immunol; 2013 Jun; 190(12):6673-80. PubMed ID: 23686489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CCR2 defines a distinct population of NK cells and mediates their migration during influenza virus infection in mice.
    van Helden MJ; Zaiss DM; Sijts AJ
    PLoS One; 2012; 7(12):e52027. PubMed ID: 23272202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macrophage and cancer cell cross-talk via CCR2 and CX3CR1 is a fundamental mechanism driving lung cancer.
    Schmall A; Al-Tamari HM; Herold S; Kampschulte M; Weigert A; Wietelmann A; Vipotnik N; Grimminger F; Seeger W; Pullamsetti SS; Savai R
    Am J Respir Crit Care Med; 2015 Feb; 191(4):437-47. PubMed ID: 25536148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CCL2-CCR2 axis promotes metastasis of nasopharyngeal carcinoma by activating ERK1/2-MMP2/9 pathway.
    Yang J; Lv X; Chen J; Xie C; Xia W; Jiang C; Zeng T; Ye Y; Ke L; Yu Y; Liang H; Guan XY; Guo X; Xiang Y
    Oncotarget; 2016 Mar; 7(13):15632-47. PubMed ID: 26701209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model.
    Teng KY; Han J; Zhang X; Hsu SH; He S; Wani NA; Barajas JM; Snyder LA; Frankel WL; Caligiuri MA; Jacob ST; Yu J; Ghoshal K
    Mol Cancer Ther; 2017 Feb; 16(2):312-322. PubMed ID: 27980102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atypical chemokine receptor ACKR2 controls branching morphogenesis in the developing mammary gland.
    Wilson GJ; Hewit KD; Pallas KJ; Cairney CJ; Lee KM; Hansell CA; Stein T; Graham GJ
    Development; 2017 Jan; 144(1):74-82. PubMed ID: 27888192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of a functional CCR2 receptor enhances tumor localization and tumor eradication by retargeted human T cells expressing a mesothelin-specific chimeric antibody receptor.
    Moon EK; Carpenito C; Sun J; Wang LC; Kapoor V; Predina J; Powell DJ; Riley JL; June CH; Albelda SM
    Clin Cancer Res; 2011 Jul; 17(14):4719-30. PubMed ID: 21610146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toll-like receptor 2 activation induces C-C chemokine receptor 2-dependent natural killer cell recruitment to the peritoneum.
    Haidl ID; Meghnem D; Issekutz TB; Marshall JS
    Immunol Cell Biol; 2020 Nov; 98(10):854-867. PubMed ID: 32696994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CCR2-positive monocytes recruited to inflamed lungs downregulate local CCL2 chemokine levels.
    Maus UA; Wellmann S; Hampl C; Kuziel WA; Srivastava M; Mack M; Everhart MB; Blackwell TS; Christman JW; Schlöndorff D; Bohle RM; Seeger W; Lohmeyer J
    Am J Physiol Lung Cell Mol Physiol; 2005 Feb; 288(2):L350-8. PubMed ID: 15516494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional aberrant expression of CCR2 receptor on chronically activated NK cells in patients with TAP-2 deficiency.
    Hanna J; Mussaffi H; Steuer G; Hanna S; Deeb M; Blau H; Arnon TI; Weizman N; Mandelboim O
    Blood; 2005 Nov; 106(10):3465-73. PubMed ID: 16037391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Killer cell lectin-like receptor G1 binds three members of the classical cadherin family to inhibit NK cell cytotoxicity.
    Ito M; Maruyama T; Saito N; Koganei S; Yamamoto K; Matsumoto N
    J Exp Med; 2006 Feb; 203(2):289-95. PubMed ID: 16461340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Role of Atypical Chemokine Receptor D6 (ACKR2) in Physiological and Pathological Conditions; Friend, Foe, or Both?
    Gowhari Shabgah A; Jadidi-Niaragh F; Mohammadi H; Ebrahimzadeh F; Oveisee M; Jahanara A; Gholizadeh Navashenaq J
    Front Immunol; 2022; 13():861931. PubMed ID: 35677043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spread of Psoriasiform Inflammation to Remote Tissues Is Restricted by the Atypical Chemokine Receptor ACKR2.
    Shams K; Wilson GJ; Singh M; van den Bogaard EH; Le Brocq ML; Holmes S; Schalkwijk J; Burden AD; McKimmie CS; Graham GJ
    J Invest Dermatol; 2017 Jan; 137(1):85-94. PubMed ID: 27568525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CCR2 expression by brain microvascular endothelial cells is critical for macrophage transendothelial migration in response to CCL2.
    Dzenko KA; Song L; Ge S; Kuziel WA; Pachter JS
    Microvasc Res; 2005 Jul; 70(1-2):53-64. PubMed ID: 15927208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer.
    Smyth MJ; Teng MW; Swann J; Kyparissoudis K; Godfrey DI; Hayakawa Y
    J Immunol; 2006 Feb; 176(3):1582-7. PubMed ID: 16424187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NLRP3 suppresses NK cell-mediated responses to carcinogen-induced tumors and metastases.
    Chow MT; Sceneay J; Paget C; Wong CS; Duret H; Tschopp J; Möller A; Smyth MJ
    Cancer Res; 2012 Nov; 72(22):5721-32. PubMed ID: 22986739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural killer cells require selectins for suppression of subcutaneous tumors.
    Sobolev O; Stern P; Lacy-Hulbert A; Hynes RO
    Cancer Res; 2009 Mar; 69(6):2531-9. PubMed ID: 19258505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.